Authors: Forslund, A Lonnroth, C Andersson, M Brevinge, H Lundholm, K

Citation: A. Forslund et al., Mutations and allelic loss of p53 in primary tumor DNA from potentially cured patients with colorectal carcinoma, J CL ONCOL, 19(11), 2001, pp. 2829-2836

Authors: Kilhamn, J Brevinge, H Quiding-Jarbrink, M Svennerholm, AM Jertborn, M

Citation: J. Kilhamn et al., Induction and distribution of intestinal immune responses after administration of recombinant cholera toxin B subunit in the ileal pouches of colectomized patients, INFEC IMMUN, 69(5), 2001, pp. 3466-3471

Authors: Kilhamn, J Brevinge, H Quiding-Jarbrink, M Svennerholm, AM Jertborn, M

Citation: J. Kilhamn et al., Induction and distribution of intestinal immune responses after administration of recombinant cholera toxin B subunit in the ileal pouches of colectomized patients (vol 69, pg 3466, 2001), INFEC IMMUN, 69(10), 2001, pp. 6564-6564

Authors: Yang, Y Forslund, A Remotti, H Lonnroth, C Andersson, M Brevinge, H Svanberg, E Lindner, P Hafstrom, L Naredi, P Lundholm, K

Citation: Y. Yang et al., p53 mutations in primary tumors and subsequent liver metastases are related to survival in patients with colorectal carcinoma who undergo liver resection, CANCER, 91(4), 2001, pp. 727-736

Authors: Bertario, L Bader, JP Besbeas, SS Brevinge, H Castiglione, G Crespi, M Dubois, G Faivre, J Fric, P Giacosa, A Gnauck, R Hardcastle, JD Gutierrez, JMH Jorgensen, OD Kronborg, O Maltoni, G Wahrendorf, J Zappa, M Zavoral, M

Citation: L. Bertario et al., Recommendation to include colorectal cancer screening in public health policy, J MED SCREE, 6(2), 1999, pp. 80-81

Authors: Daneryd, P Svanberg, E Korner, U Lindholm, E Sandstrom, R Brevinge, H Pettersson, C Bosaeus, I Lundholm, K

Citation: P. Daneryd et al., Protection of metabolic and exercise capacity in unselected weight-losing cancer patients following treatment with recombinant erythropoietin: A randomized prospective study, CANCER RES, 58(23), 1998, pp. 5374-5379